Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|February 6, 2025
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamstersJyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Indian Heart Journal|May 28, 2010
3D echocardiography: "The most powerful predictor of masked CVD in metabolic syndrome"H K Chopra, K K Aggarwal, C K Krishna, et al.
JACC. Asia|June 30, 2026
Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide StudyRaman Puri, Manish Bansal, Kunal Mahajan, et al.
International Journal of Cardiology|October 23, 2022
Infective endocarditis in adult patients with congenital heart diseaseJoost P van Melle, Jolien W Roos-Hesselink, Manish Bansal, et al.
JACC. Advances|January 16, 2025
Systemic Sirolimus Therapy Is Associated With Reduced Intervention Frequency in Pulmonary Vein StenosisAlyssa B Kalustian, Joseph L Hagan, Paige E Brlecic, et al.
Veterinary Microbiology|May 17, 2011
Zoonotic cases of camelpox infection in IndiaB C Bera, K Shanmugasundaram, Sanjay Barua, et al.
Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.
The Lancet. Infectious Diseases|November 28, 2021
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesRamachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, et al.
The European Respiratory Journal|June 2, 2019
Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertensionCsaba Galambos, Mary P Mullen, Joseph T Shieh, et al.
Journal of Clinical Lipidology|May 4, 2022
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.
Pageof 22